Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9409741 | 0.91 | GSK3B (0.70) | GSK3BPTPN1ATMTDP1L3MBTL1 | |
| SCHEMBL689178 | 0.84 | ATM (0.52) | ATMTDP1L3MBTL1 | |
| SCHEMBL1447797 | 0.83 | GSK3B (0.65) | GSK3BPTPN1 | |
| SCHEMBL18380618 | 0.82 | GSK3B (0.57) | GSK3BPTPN1TDP1 | |
| SCHEMBL2798050 | 0.82 | GSK3B (0.57) | GSK3BPTPN1TDP1L3MBTL1 | |
| SCHEMBL684561 | 0.80 | GSK3B (0.55) | GSK3BPTPN1 | |
| SCHEMBL27588759 | 0.80 | GSK3B (0.55) | GSK3BPTPN1 | |
| SCHEMBL316026 | 0.79 | GSK3B (0.59) | GSK3BPTPN1L3MBTL1 | |
| SCHEMBL1361623 | 0.79 | GSK3B (0.59) | GSK3BPTPN1 | |
| SCHEMBL30517873 | 0.79 | GSK3B (0.59) | GSK3BPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150158844-A1 | AROMATIC HETEROCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-11 | — | — | US | disclosed |
| US-20150158844-A1 | AROMATIC HETEROCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150158844-A1 | AROMATIC HETEROCYCLIC COMPOUND | GPR119, NR0B1, BET1 | GSK3B 4564/4885PTPN1 181/4885ATM 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.